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Summary
Campylobacter jejuni is the foremost cause of
bacterial-induced diarrhoeal disease worldwide.
Although it is well established that C. jejuni infection
of intestinal epithelia triggers host innate immune
responses, the mechanism(s) involved remain poorly
defined. Innate immunity can be initiated by families
of structurally related pattern-recognition receptors
(PRRs) that recognize specific microbial signature
motifs. Here, we demonstrated maximal induction of
epithelial innate responses during infection with live
C. jejuni cells. In contrast when intestinal epithelial
cells (IECs) were exposed to paraformaldehyde-fixed
bacteria, host responses were minimal and a marked
reduction in the number of intracellular bacteria was
noted in parallel. These findings suggested a role for
intracellular host–C. jejuni interactions in eliciting
early innate immunity. We therefore investigated the
potential involvement of a family of intracellular, cyto-
plasmic PRRs, the nucleotide-binding oligomeriza-
tion domain (NOD) proteins in C. jejuni recognition.
We identified NOD1, but not NOD2, as a major PRR for
C. jejuni in IEC. We also found that targeting intestinal
epithelial NOD1 with small interfering RNA resulted in
an increase in number of intracellular C. jejuni, thus
highlighting a critical role for NOD1-mediated anti-
microbial defence mechanism(s) in combating this
infection at the gastrointestinal mucosal surface.
Introduction
Campylobacter jejuni is the most prevalent cause of bac-
terial diarrhoea worldwide and the leading cause of infec-
tious enterocolitis in the Western world (Mead et al., 1999;
Allos, 2001). C. jejuni colonizes and survives as a com-
mensal in the gastrointestinal (GI) tract of many birds and
other animals (Park, 2002), however, in humans as few as
500 bacteria can cause symptomatic disease (Black
et al., 1988). Undercooked poultry, cross-contamination of
other foods with raw poultry, contaminated water and
unpasteurized dairy products are known sources of
human infection (Humphrey, 2006). Clinical symptoms
typically manifest with cramping abdominal pain, vomiting
and fever followed by mild, watery or inflammatory and
bloody diarrhoea (Lambert et al., 1979; Black et al., 1988;
Lamps et al., 2006). Although C. jejuni-mediated diar-
rhoea is the ‘classical’ clinical manifestation in majority of
individuals, in some people further complications can
arise. These include Guillain–Barré Syndrome (GBS) a
paralysis occurring 2–3 weeks post infection (Goodyear
et al., 1999), and longer term sequelae such as reactive
arthritis (Peterson, 1994; Leirisalo-Repo, 2005).
Despite the serious health burden caused by this bac-
terium, our current understanding of C. jejuni-mediated
disease pathogenesis remains limited. The self-limiting
nature of C. jejuni-mediated diarrhoea clearly indicates
that effective immune defence mechanism(s) are opera-
tive in healthy individuals allowing for successful, rapid
clearance of infection. As the first site of bacterial contact,
the intestinal epithelial cell (IEC) plays a critical role in
initiating host defence to enteropathogens (Islam et al.,
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2001; Eckmann, 2005; Sansonetti and Di Santo, 2007).
Our own previous work has indicated that endogenous
antimicrobials such as b-defensins may be directly
involved in controlling infection as these peptides are
induced by C. jejuni and exhibit potent bactericidal activity
against the organism (Zilbauer et al., 2005). Studies have
also demonstrated secretion of the potent neutrophil
chemoattractant interleukin-8 (IL-8) by IECs in response
to wild-type (WT) C. jejuni (Hickey et al., 1999; 2000;
Watson and Galan, 2005; Johanesen and Dwinell, 2006).
Both bacterial structural [e.g. cytolethal distending toxin
(CDT)] components and active processes such as
adhesion/invasion and de novo protein synthesis have
been implicated in eliciting epithelial innate immune
responses (Hickey et al., 2000; Mellits et al., 2002;
Watson and Galan, 2005). Despite advances in our
understanding of the role and contribution of bacterial
factors implicated in C. jejuni-mediated epithelial
responses, at present our knowledge remains rudimen-
tary as to how the host senses and initiates an effective
immune response to the presence of the bacterium.
Innate recognition of microorganisms is an ancient
mode of defence shared throughout the plant and animal
kingdom (Ganz, 2003; Akira, 2006). A triad of pattern-
recognition receptor (PRR) families are now known to be
involved in recognizing invariant structures or pathogen-
associated molecular patterns (PAMPs) on microorgan-
isms (Inohara et al., 2005; Takeda and Akira, 2005;
Franchi et al., 2006; Werts et al., 2006). The most exten-
sively studied PRRs are the Toll-like receptors (TLRs),
which comprise evolutionarily conserved transmembrane
proteins that recognize bacterial structural components
such as lipopolysacchride (LPS), flagellin, lipoproteins,
lipoteichoic acid and unmethylated CpGDNA (Janeway
and Medzhitov, 2002; Akira, 2006). Recent evidence sug-
gests that Campylobacter flagellin is a poor ligand for IEC
TLR5 playing no significant role in bacterial-mediated host
epithelial responses (Watson and Galan, 2005). The
potential role and contribution of other epithelial TLRs to
C. jejuni recognition at present is unclear.
The well recognized ‘invasive’ nature of C. jejuni drew
our attention to elucidate the contribution, if any, of the
second PRR family, i.e. the cytoplasmic nucleotide-
binding oligomerization domain (NOD) proteins to IEC
innate immunity (Inohara et al., 2005). NOD1 (encoded by
the caspase-recruitment domain 4 gene; CARD4) and
NOD2 (encoded by CARD15) recognize components of
peptidoglycans (PGNs), ubiquitous constituents of bacte-
rial cell walls (Inohara and Núňez, 2003; Inohara et al.,
2005; Franchi et al., 2006). The minimal PGN structure
that acts as a specific ligand for NOD1/CARD4 is
g-D-glutamyl-meso-diaminopimelic acid (iE-DAP), a signa-
ture motif found in most Gram-negative and some
Gram-positive bacterial PGNs (Chamaillard et al., 2003;
Girardin et al., 2003a). In contrast, NOD2/CARD15 is
a more global bacterial sensor as it interacts
with N-acetylmuramyl-L-alanyl-D-isoglutamine [muramyl
dipeptide (MDP)], a motif common to both Gram-negative
and Gram-positive bacterial PGNs (Girardin et al., 2003b;
Inohara and Núňez, 2003).
In the present study we investigated the potential role of
NOD1 and NOD2 as cytoplasmic PRRs involved in initi-
ating host IEC innate immunity in response to C. jejuni.
We observed marked increase in IEC IL-8 and human
b-defensin 2 (hBD2) expression in response to infection
with live C. jejuni cells. In contrast, fixed-bacteria were
significantly impaired in eliciting IEC immune responses.
Five hours post infection, live C. jejuni infection resulted in
the presence of intracellular bacterial cells whereas
paraformaldehyde (PFA)-fixed C. jejuni exhibited a pre-
dominant extracellular location. The presence of intracel-
lular bacteria coupled to potent innate immune induction
makes the involvement of cytoplasmic PRRs such as the
NOD family more likely in C. jejuni-mediated host cellular
events.
Specific knock down of NOD1 in Caco-2 cells led to
significant reduction in C. jejuni-driven innate immune
transcriptional activity, gene and protein expression.
These effects were observed during infections with two
well characterized C. jejuni clinical isolates 11168H and
81–176. Importantly, reduced NOD1 expression resulted
in an increase in number of intracellular C. jejuni implicat-
ing NOD1 as a major PRR responsible for initiating bac-
tericidal defence mechanism(s) against this bacterium.
We also provide evidence that NOD2, a close relative of
NOD1 plays a minimal role in intestinal epithelial innate
immunity to C. jejuni.
Results
Intracellular C. jejuni bacterial component(s) play an
important role in eliciting IEC innate immunity
Previous studies have shown that C. jejuni induces
expression of several chemokines including IL-8 on
contact with IECs (Hickey et al., 1999; Hu and Hickey,
2005) and that bacterial de novo protein synthesis is
required for IL-8 production (Watson and Galan, 2005).
Prior to investigating the role of cytoplasmic NOD proteins
as potential PRR(s) for C. jejuni, it was pertinent to estab-
lish a link between epithelial responses and bacterial
localization in our co-culture model system. For this
purpose, we compared epithelial responses of live versus
PFA-fixed C. jejuni. PFA treatment allows maintenance of
the structural integrity of the bacterial cells (albeit with
reduced ability for conformational changes) while render-
ing the bacteria non-viable and unable to execute and
participate in active, energy requiring processes. We
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observed potent induction of epithelial IL-8 and hBD2
gene expression in the presence of infection with live
C. jejuni 11168H and 81–176 cells, with the response
markedly reduced on exposure to PFA-fixed cells (Fig. 1a
and b). Potency of infection with live bacteria was also
confirmed at the protein level. In comparison PFA-fixed
bacteria showed a significant reduction in their ability to
induce IL-8 protein (Fig. 1c). Bacterial localization was
investigated 5 h post-infection. C. jejuni was detected
both intracellularly (green) and extracellularly (yellow;
merged image) following infection with live 81–176 strain
(Fig. 1d; merged upper panel). In contrast, PFA-fixed
Fig. 1. a–c. Differential induction of intestinal
epithelial cell (IEC) IL-8 and hBD2 expression
in response to live and paraformaldehyde
(PFA)-fixed C. jejuni cells. Caco-2 cells were
infected with live or PFA-fixed WT C. jejuni
strains 11168H (a) and 81–176 (b). A
representative gel for infection with each
wild-type strain is shown. Eight hours post
infection, IL-8 and hBD2 gene expression was
measured by RT-PCR and normalized against
GAPDH expression. Quantification of IL-8
protein levels was performed by ELISA (c).
Error bars indicate standard error of mean
(SEM) obtained from a minimum of two
independent experiments performed in
duplicate. *P < 0.05; live versus PFA-fixed
C. jejuni cells.
d. Intracellular localization of live C. jejuni
cells 5 h post infection. Caco-2 cells were
co-cultured with live or PFA-fixed
FITC-labelled C. jejuni 81–176 (green) for 5 h.
To distinguish between intra- and extracellular
bacterial localization, non-permeabilized cells
were stained with anti-C. jejuni antibodies
followed by Alexa Fluor 568 conjugated rabbit
anti-goat IgG. The latter treatment allowed for
additional staining of extracellular
FITC-labelled bacteria leading to a yellow
appearance (merging of green FITC and red
Alexa Fluor-568). In contrast, intracellular
bacteria remained green. Nuclei were
counterstained with TO-PRO-3 (blue in
merged image). Intracellular bacterial
localization is highlighted (arrowheads). A
representative image from two experiments
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bacteria showed mainly extracellular localization (Fig. 1d;
merged lower panel). The marked reduction in the pres-
ence of intracellular C. jejuni cell components(s) during
infection with PFA-fixed bacteria may contribute to the
observed lack of induction of epithelial innate immunity.
Intestinal epithelial NOD1 and NOD2 gene expression is
not modulated in response to C. jejuni
Bacterial adherence to and subsequent invasion of the
IEC is a well established early event in C. jejuni-
mediated disease pathogenesis (Konkel and Joens,
1989; Szymanski et al., 1995; Monteville et al., 2003).
The causal association of presence of intracellular bac-
teria with potent IEC responses (Fig. 1) added weight to
our initial hypothesis that epithelial cytoplasmic NOD
protein(s) may be potential PRR(s) for C. jejuni. We con-
firmed the constitutive expression of NOD1 in Caco-2
(Fig. 2; upper panel) and HT-29 cell-lines (data not
shown). Interestingly, no modulation of NOD1 expres-
sion was noted during C. jejuni infection up to 24 h post
infection, irrespective of bacterial strain tested (Fig. 2a
and b) or cell-line used. Evidence for infectivity was
sought in parallel. This was investigated by following the
expression of hBD2; a bactericidal molecule whose
expression is known to be dependent on NOD1 engage-
ment (Boughan et al., 2006). No hBD2 expression was
noted in control, uninfected Caco-2 cell-line (Fig. 2;
second panel). In response to infection with two different
wild-type strains (11168H and 81–176), we observed
induction of hBD2; with initial expression noted as early
as 6 h post infection (Fig. 2; second panel). To delineate
a role for NOD2 as a potential PRR for C. jejuni, we
followed the expression of this molecule during infection.
NOD2 expression was not observed in either uninfected
or C. jejuni-infected Caco-2 cells throughout the 24 h
course of infection (Fig. 2; third panel). Similarly, no
NOD2 expression was noted in infected HT-29 cells
(data not shown). Macrophages in peripheral blood
mononuclear cells (PBMCs) are known to express
NOD2 and were therefore included in each experiment
as a positive control.
The presence of NOD1 small interfering (si) RNA
inhibits IL-8 and hBD2 gene expression in response to
C. jejuni infection
We next wished to establish if intestinal epithelial NOD1
was involved in C. jejuni-mediated epithelial responses.
Two distinct siRNA sequences specifically targeting
NOD1 (siNOD1 a and b) were transiently transfected into
Caco-2 cells and NOD1 gene knock down was investi-
gated 48 h post-transfection by reverse transcription poly-
merase chain reaction (RT-PCR). Specificity of gene
silencing was confirmed (Fig. 3a and b, third panel).
Importantly, transfection of a non-targeting, control siRNA
sequence (siNEG) did not affect NOD1 expression
(Fig. 3a and b, third panel). Transfected Caco-2 cells were
co-cultured with 11168H (Fig. 3a) and 81–176 (Fig. 3b)
strains for 8 h. IL-8 and hBD2 gene expression was
inhibited following transfection with siNOD1 (a and b),
implicating NOD1 in C. jejuni-mediated IEC innate
immune responses.
More detailed analysis of the role of NOD1 in C. jejuni-
driven IEC transcriptional and translational innate immu-
nity was sought. We found a dose-dependent inhibitory
effect of siNOD1 on C. jejuni-mediated IL-8 promoter
activity (Fig. 3c and d). Dose-dependency was tested at
10 and 20 nM concentration for siNOD1 a and b
sequences. Thirty to fifty per cent inhibition of IL-8 tran-
scription activity index was routinely achieved in the pres-
ence of transfected siNOD1 irrespective of the bacterial
strain or sequence tested (Fig. 3c and d). In parallel
experiments, siNEG sequence was found to have no
effect on IL-8 promoter activity, further highlighting speci-
ficity of NOD1 knockout and its biological consequences
on IL-8 promoter activity. Once the greater inhibition of
siNOD1 sequences at 20 nM was established, the effect
of this concentration on hBD2 promoter activity was
tested. As shown in Fig. 3e and f, there was 50–60%
reduction in C. jejuni-mediated hBD2 promoter activity in





WT C. jejuni 11168H
hBD2
CON 6 h           10 h           24 h         PBMCs
NOD2
Fig. 2. Intestinal epithelial NOD1 and NOD2 expression is not
modulated during C. jejuni infection. Caco-2 cell-line were
co-cultured with C. jejuni wild-type 11168H (a) or 81–176 (b) strains
for up to 24 h. Time-dependant gene expression of NOD1 (upper
panel) and NOD2 (third panel) was followed by RT-PCR. In
parallel, evidence for infectivity was confirmed by observing
increase in hBD2 expression (second panel). Peripheral blood
mononuclear cells (PBMCs) served as positive control for NOD2.
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for this intracellular PRR in C. jejuni-mediated IEC
responses. As observed for IL-8 (Fig. 3c and d), infections
performed in the presence of siNEG had minimal effect on
hBD2 transcriptional activity.
NOD1 gene silencing not only inhibited bacterial-
induced IL-8 promoter and gene function in Caco-2 cells
but also markedly reduced protein expression (Fig. 3g).
Induction of IL-8 protein in response to infection with
C. jejuni 11168H and 81–176 strains was significantly
inhibited in the presence of both siNOD1 a and b
sequences with siNEG exhibiting no significant effect.
This series of experiments unequivocally highlighted
NOD1 as a critical sensor and signalling molecule in
C. jejuni-mediated IEC responses.
NOD2 plays a minimal role in intestinal epithelial
immune defence against C. jejuni
Experiments described above showed that NOD2 gene
expression was not seen in resting or C. jejuni-stimulated
epithelial cells (Fig. 2). However, during an in vivo infec-
tion, intestinal epithelial homeostasis is likely to be influ-
enced indirectly by neighbouring inflammatory immune
cells and their secretory products such as cytokines, mol-
ecules known to modulate NOD2 expression (Gutierrez
et al., 2002; Rosenstiel et al., 2003). To establish if epi-
thelial NOD2 (when expressed under inflammatory con-
ditions) may also act as a potential PRR for C. jejuni, we
transiently transfected Caco-2 cells with a plasmid over-
expressing NOD2. NOD2 gene expression 48 h post-
transfection was confirmed by RT-PCR (Fig. 4a and c;
third panel). Control and NOD2 transfected Caco-2 cells
were exposed to C. jejuni wild-type strains 11168H
(Fig. 4a) and 81–176 (Fig. 4c). Infection with either strain
resulted in no enhanced IL-8 or hBD2 gene expression
(Fig. 4a and c). Similarly, no increase in C. jejuni-
mediated IL-8 and hBD2 promoter activity was noted in
the presence of NOD2 when compared with control cells
lacking NOD2 (Fig. 4b and d).
Streptococcus pneumoniae (a causative agent for
bacterial meningitis) transiently invades epithelial cells
and uses NOD2 as a PRR (Opitz et al., 2004). To
confirm that the transfected NOD2 gene in our cell
culture system was biologically active, we included
S. pneumoniae infection as a control. As noted for gene
expression, the presence of NOD2 had no effect on the
levels of IL-8 protein production in response to C. jejuni
strains 11168H or 81–176 (Fig. 4e). In contrast, a sig-
nificant increase in IL-8 protein levels was observed in
NOD2-transfected Caco-2 cells in response to S. pneu-
moniae compared with infection in control, untransfected
cells. These data clearly suggest that, unlike S. pneumo-
niae, C. jejuni does not engage NOD2 in mediating IEC
innate responses.
Intestinal epithelial cell NOD1 engagement mediates
antimicrobial defence against C. jejuni
Although the data presented above highlights NOD1 as a
major PRR in IL-8 and hBD2 expression (Fig. 3), the
impact of IEC immunity on subsequent bacterial–host
interactions remains poorly defined. To investigate the
biological consequence of NOD1-mediated antimicrobial
activity on C. jejuni, bacterial co-culture studies were per-
formed on control untransfected, siNEG, siNOD1a,
siNOD1b and NOD2 transfected Caco-2 cells. 20 h post
infection with 81–176 strain, cells were washed and sub-
jected to a standard gentamicin protection assay. Lysed
cell suspensions were diluted and viable intracellular bac-
teria enumerated by counting the colony-forming units
(cfu) on blood agar plates. Each experiment was per-
formed in triplicate. Data of two similar experiments are
schematically shown in Fig. 5. No significant difference in
the number of intracellular bacteria was noted between
control untransfected Caco-2 cells and those transfected
with siNEG. This was an important observation as it high-
lighted that introducing a non-targeting siRNA molecule
did not interfere with host responses under investigation.
Most importantly, the specific knock-down of NOD1
(siNOD1 a and b) during infection greatly enhanced the
number of intracellular C. jejuni cells. Our study is the first
to implicate IEC NOD1 function in modulating the intrac-
ellular presence of C. jejuni. In contrast, the additional
presence of NOD2 did not appear to modulate the number
of intracellular bacteria when compared with control
untransfected cells.
Fig. 3. Inhibition of C. jejuni-mediated IL-8 and hBD2 expression in the presence of NOD1 small interfering (si) RNA. Caco-2 cells were
reverse-transfected with two distinct siRNA sequences targeting NOD1 (siNOD1 a and b) and a non-targeting (siNEG) sequence. For
luciferase reporter gene analyses, cells were cotransfected with promoter constructs for IL-8 (c and d) and hBD2 (e and f) 24 h post siRNA
treatment. Following a further 24 h incubation transfected cells were co-cultured with C. jejuni wild-type strains for 8 h.
a and b. IL-8 and hBD2 gene expression was followed post infection by RT-PCR. A representative gel for infection with each wild-type strain is
shown.
c and d. siNOD1 dose-dependent inhibition of C. jejuni 11168H (c) and 81–176 (d)-mediated IL-8 promoter activity.
e and f. Significant inhibition of C. jejuni-mediated hBD2 transcriptional activity in the presence of 20 nM siNOD1 targeting sequences.
g. Marked inhibition of C. jejuni-mediated IL-8 protein production in the presence of siNOD1 targeting. Treatment with non-targeting siNEG had
no significant effect on IL-8 protein levels as measured by ELISA. *P < 0.05 versus IL-8 and hBD2 induction in untreated and non-targeting
siRNA treated Caco-2 cells.
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Fig. 4. NOD2 plays a minimal role in C. jejuni-mediated IL-8 and hBD2 induction. Caco-2 cells were transiently transfected with NOD2
overexpressing plasmid for 48 h followed by infection with C. jejuni WT 11168H (a and b) or 81–176 (c and d) strains for 8 h. IL-8 and hBD2
gene expression was analysed by RT-PCR (a and c) and their transcriptional activity quantified by promoter luciferase reporter assay (b and
d). The potential effect of the presence of NOD2 on bacterial-mediated IL-8 protein level was also investigated (e). Encapsulated
S. pneumoniae (serotype F19) was included as a positive control as it is known to use NOD2 as a PRR.
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Discussion
The pathogenesis of C. jejuni-mediated enterocolitis and
related complications in humans remains ill defined. The
self-limiting nature of infection coupled with lack of a reli-
able animal model reflecting human campylobacteriosis
have proved to be major stumbling blocks to our current
understanding of disease aetiology. Despite the availability
of the genome sequences of the three strains NCTC11168,
RM1221 and 81–176 (Parkhill et al., 2000; Fouts et al.,
2005; Hofreuter et al., 2006), little is known about the
mechanism(s) by which C. jejuni triggers host responses.
Once bacterial contact with intestinal epithelium is
established, enteropathogens rely on multiple strategies
to ensure optimal, dynamic interactions with the host. One
such strategy that C. jejuni shares with other intestinal
pathogens such as Salmonella, Shigella and Yersinia
species is host cell invasion (Kopecko et al., 2001; Ellison
et al., 2004; Nhieu et al., 2005). Activation of multiple IEC
signal transduction pathways is known to occur upon
adhesion and invasion of C. jejuni, in particular IL-8 pro-
duction has been shown to be intimately linked with these
early cellular events (Konkel and Cieplak, 1992;
Oelschlaeger et al., 1993; Kopecko et al., 2001; Biswas
et al., 2003; Mooney et al., 2003; Hu and Hickey, 2005;
Watson and Galan, 2005).
In the present study we used two different C. jejuni
wild-type strains (11168H and 81–176) known to exhibit
varying invasive capacity (MacCallum et al., 2005); (A.
Elmi and N. Dorrell, unpub. data). In addition, C. jejuni
81–176 harbours a putative virulence plasmid (pVir)
encoding a potential type IV secretion system, which
has been implicated in invasion of intestinal epithelia
(Bacon et al., 2000). Interestingly, in our co-culture
studies both 11168H and 81–176 strains elicited similar
IL-8 gene and protein induction, the differences noted
were not statistically significant (Fig. 1a–c). We also
observed similar induction (three- to four-fold increase)
in IL-8 and hBD2 promoter transcriptional activity in
response to the two strains in HT-29 cells (data not
shown). Our data not only confirms previous studies
where a trend for increased IL-8 protein production with
more invasive C. jejuni strains has been noted (Fig. 1c;
Watson and Galan, 2005; Johanesen and Dwinell,
2006), but we extend these findings by suggesting that
11168H and 81–176 do not exhibit significantly different
effects on IEC immune gene transcription.
Despite the lack of complete correlation between the
degree of C. jejuni invasion and IEC IL-8 protein induc-
tion, the process of ‘invasion’ itself is a crucial event
involved in eliciting innate immune responses. Experi-
ments conducted in the presence of PFA-fixed bacteria
showed marked absence of intracellular C. jejuni cells
and correspondingly, IECs exhibited weak IL-8 protein
production, thus clearly identifying the requirement for
C. jejuni cell components within the IEC cytoplasm for
optimal host response.
An ancient, universal strategy that allows host-
pathogen cross-talk to take place is the interaction of
microbial PAMPs with corresponding host receptors aptly
called PRRs (Akira, 2006; Franchi et al., 2006). TLRs
were the first family to be implicated as PRRs in host
innate recognition. Unlike Salmonella which engages host
TLR5, C. jejuni flagellin has been found to have weak
immune-stimulatory properties with minimal interaction
with IEC TLR5 (Andersen-Nissen et al., 2005; Watson
and Galan, 2005; Johanesen and Dwinell, 2006). The
information that bacterial invasion is crucial for IEC immu-
nity, coupled with minimal involvement of TLR5 led us to
hypothesize that the intracellular NOD family could be
likely PRR(s) for C. jejuni.
Peptidoglycans (PGNs) are ubiquitous constituents of
bacterial cell walls. PRRs involved in PGN recognition are
the intracellular NOD proteins, members of the Apaf-1/
CARD superfamily (Inohara et al., 2002; Philpott and
Girardin, 2004; Franchi et al., 2006; Fritz et al., 2006;
Strober et al., 2006). NOD1 is constitutively expressed in
IEC with minimal expression of its close homologue
NOD2 observed under control conditions. In contrast,
NOD2 is abundant in Paneth cells of the small intestine
and in antigen-presenting cells (Ogura et al., 2001; Koba-
yashi et al., 2005). We first wished to investigate if























Fig. 5. Absence of intestinal epithelial NOD1 leads to increase in
number of intracellular C. jejuni cells. Caco-2 cells were
reverse-transfected with siRNA (sequences a and b) targeting
NOD1 or with siNEG or with plasmid expressing NOD2.
Non-treated Caco-2 cells served as control. Forty-eight hours
post-transfection, cells were co-cultured with live WT C. jejuni
81–176 for 20 h prior to enumeration of intracellular bacteria. Data
represent average percentage colony-forming units (cfu) obtained
in treated versus untreated Caco-2 cells (the latter set as 100%).
Statistical analysis of two to three independent experiments
performed in triplicate is shown. **P < 0.001 versus untreated
Caco-2 cells.
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potential PRR(s). Using two different cell-lines (Caco-2
and HT -29; data for the latter cell-line not shown) and two
bacterial wild-type strains in co-culture experiments, we
found no significant modulation of NOD1 expression in
the 24 h infection period (Fig. 2; top panel). This was an
important observation as it suggests that the bacterium
does not directly modulate NOD1 expression as an early
immune evasion strategy. However, due to the limitations
of an in vitro cell-line model of infection, one cannot rule
out bacterial-driven changes in NOD1 expression and
function in an ongoing infection in vivo. Cytokines such as
IFN-g are known to augment NOD1 expression (Hisa-
matsu et al., 2003a) suggesting greater complexity to
C. jejuni/epithelial NOD1 interactions in an on-going
inflammatory episode are likely. NOD2 gene expression
was not detected in control Caco-2 cells (Fig. 2; third
panel) and infection with either C. jejuni strain did not
result in NOD2 induction, suggesting that it is NOD1 and
not NOD2 that is likely to be a potential PRR for C. jejuni
in our model system. In the same experiments, we con-
firmed appropriate infectivity by following the expression
of hBD2, a peptide whose expression is NOD1 activation-
dependent (Boughan et al., 2006). Induction of hBD2 in
the absence of NOD2 clearly implicated NOD1 as a
potential intracellular sensor for C. jejuni.
Next, we sought evidence for a functional role for NOD1
in C. jejuni infection. For this purpose we transiently trans-
fected two NOD1 siRNA sequences prior to exposure of
cells to C. jejuni. We observed dose-dependent inhibition
in IL-8 promoter luciferase activity in the presence of both
sequences with significant reduction at 20 nM concentra-
tion (Fig. 3). Although marked knock-down of the NOD1
gene was observed (Fig. 3a and b) its corresponding
inhibitory effect on IL-8 and hBD2 gene and promoter
function (Fig. 3a–f) ranged between 40% and 60%, sug-
gesting NOD1-independent signalling events are also
involved in IEC innate immune gene regulation. Several
studies have implicated MAP kinase pathways in
C. jejuni-mediated IL-8 production (MacCallum et al.,
2005; Watson and Galan, 2005) and it is most likely that
they are also operative in our model system.
Studies by Podolsky and colleagues have suggested a
role for NOD2 in intestinal epithelial defence against Sal-
monella infection (Hisamatsu et al., 2003b). In our study,
overexpression of NOD2 by transient transfection did not
augment innate defence gene expression in response to
C. jejuni infection (Fig. 4). To validate the functionality of
transfected NOD2 in our culture system, we included live
S. pneumoniae infection as a positive control as Optiz and
coworkers have elegantly demonstrated NOD2 as the
intracellular PRR for this bacterium (Opitz et al., 2004).
Why Samonella and Campylobacter, two Gram-negative
enteropathogens exhibit such contrasting requirement for
NOD2 warrants further investigation.
Finally, if antibacterial immunity is generated in
response to C. jejuni infection via NOD1 activation (e.g.
hBD2 production), one can hypothesize that absence of
this armory is likely to enhance bacterial invasion and/or
survival. We followed the biological consequence of
NOD1 knock-out on C. jejuni infection. We found a
marked increase in the number of invasive bacteria 20 h
post-infection in cells treated with siNOD1a or b
sequences (Fig. 5), suggesting that NOD1-mediated cel-
lular events do contribute to the number of intracellular
bacteria, whether this is due to increased invasion or
survival or due to decrease in bacterial transcytosis
remains a question for future work (McKay et al., 2007).
The identification of NOD1 as a major sensor to entero-
invasive Escherichia coli led Kagnoff and colleagues to
propose that NOD1 signalling in the IEC may provide a
backup mechanism for rapidly activating innate immunity
during infection by highly invasive pathogenic Gram-
negative enteropathogens (Kim et al., 2004). Our study
implicating NOD1 as a major intracellular PRR for
C. jejuni, the most common cause of bacterial enterocoli-
tis lends further support for a critical role for NOD1-
mediated immunity at the GI mucosal surface. With the
identity of NOD1 as the PRR for C. jejuni now known, it is
tempting to speculate about the link between degree of
C. jejuni invasion and epithelial innate responses. With
limited NOD1 molecules in an epithelial cell, a direct cor-
relation between low levels of C. jejuni invasion and
NOD1 activation and subsequent IL-8 induction is quite
likely. However, once NOD1 and bacterial PGN interac-
tions reach saturation, enhanced invasion leading to the
presence of higher numbers of intracellular bacteria may
not trigger further chemokine responses. Further studies
are now required to investigate C. jejuni-mediated signal-
ling via NOD1 in more detail. Activation of both TLRs and
Nod-like receptors (NLRs) by different bacterial PAMPs is
emerging as an important factor in mounting an inflam-
matory response, further priming of cells with PGN result-
ing in activation of NLRs is known to have a synergistic
effect on TLR signalling (Kufer and Sansonetti, 2007).
Insight into mechanism(s) involved in C. jejuni PGN deliv-
ery, the subsequent recognition by NOD1 and possible
interplay between NLR and TLR signalling pathways will
shed greater light on the role of C. jejuni invasion in elic-
iting host responses.
Experimental procedures
Bacterial strains and culture conditions
The C. jejuni wild-type strains used in this study were 81–176, a
gastroenteritis isolate from a multistate outbreak from contami-
nated milk (Korlath et al., 1985), and 11168H, a hypermotile
isolate that was derived from the source of NCTC11168 used for
genome sequencing, which shows high levels of intestinal colo-
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nization in a chick colonization model (Jones et al., 2004).
C. jejuni was grown at 37°C in a microaerobic chamber (Don
Whitley Scientific, Shipley, UK) containing 85% N2, 5% O2 and
10% CO2 on blood agar plates consisting of Columbia agar base
(Oxoid, Basingstoke, UK) supplemented with 7% v/v defibrinated
horse blood (TCS Microbiology, Botolph Calydon, UK) or in
Mueller-Hinton (MH) broth (Oxoid). Bacteria were grown on blood
agar plates for 24 h prior to use in co-culture experiments. Bac-
terial inactivation was achieved by PFA (4%, 15 min followed by
three washes in tissue-culture media) treatment. A hundred per
cent inactivation was confirmed by viable counting.
Streptococcus pneumoniae was prepared as described
previously (Opitz et al., 2004). Briefly, WT encapsulated S. pneu-
moniae (serotype F19) was grown on Columbia agar plates
supplemented with 7% v/v defibrinated horse blood (as described
above) at 37°C with 5% CO2 over 24 h. Single colonies were
resuspended in Todd-Hewitt broth (Sigma-Aldrich, Gillingham,
UK) supplemented with 0.5% yeast extract and incubated at 37°C
for 3–4 h (100 r.p.m.) to reach midlogarithmic phase (A600-0.4).
Bacteria were harvested by centrifugation and resuspended in
tissue culture medium to a final concentration of 2 ¥ 108 cfu ml-1.
C. jejuni intestinal epithelial co-culture studies
Reagents for mammalian tissue culture, RNA extraction and
RT-PCR were obtained from Invitrogen (Paisley, UK) unless
stated otherwise. The human intestinal epithelial cell-line Caco-2
was cultured in Dulbecco’s modified essential media (DMEM)
plus GlutaMAX supplemented with 10% fetal calf serum
(FCS; Sigma-Aldrich, Gillingham, UK), 100 U ml-1 penicillin,
100 mg ml-1 streptomycin, and 1% w/v non-essential amino acids
and maintained at 37°C in 5% CO2 and 95% air. For co-culture
experiments, cells were grown in 6-well plates to >90% conflu-
ence and maintained in low serum (0.1%) and antibiotic-free
media overnight prior to co-culture with 108 cfu ml-1 [multiplicity of
infection (MOI) = 100] of bacterial cells. Infections were termi-
nated by removing the supernatant followed by two washes in
Phosphate Buffered Saline (PBS). Cells and supernatants were
frozen at -80°C until required.
RNA extraction and RT-PCR
Total RNA was isolated using a monophasic solution of phenol
and guanidine thiocyanate (TRIZOL) followed by chloroform
extraction and isopropanol precipitation. Total RNA was quanti-
fied by spectroscopy. Five micrograms of total RNA were rou-
tinely reverse-transcribed to cDNA at 42°C with 1 mg of oligo-dT
primer (Amershan-Pharmacia, St. Albans, UK), 1 mM of each
deoxynucleotide triphosphate (dNTPs) and Moloney Murine Leu-
kemia Virus (MMLV) reverse transcriptase in a volume of 20 ml,
following manufacturer’s protocol. Five microlitres (1 ml for the
housekeeping gene glyceraldehyde-3-phosphate dehydroge-
nase; GAPDH) of cDNA were amplified in the presence of
20 pmol of each oligonucleotide primer (Sigma-Aldrich, Gilling-
ham, UK), 1.5 mM MgCl2, 200 mM dNTPs and 0.5 units of Taq
polymerase. IL-8 and hBD2 primer sequences were as described
previously (Zilbauer et al., 2005).
NOD-1 primer sequences were:
• GTTGTCCAAAGCCAAACAGAAACTC (sense); and
• CAGCATCCAGATGAACGTG (antisense).
NOD-2 primer sequences were:
• ATGTGCTCGCAGGAGGCTTTTCAGGCA (sense); and
• ATGTGCTCGCAGGAGGCTTTTCAGGCA (antisense).
A 3 min hot start at 94°C was followed by amplification (dena-
turation at 94°C for 90 s, annealing 60°C for 90 s and extension
at 72°C for 90 s). PCR was allowed to continue for 34–37 cycles
ensuring reaction termination in the linear phase. PCR products
were visualized by agarose gel electrophoresis and analysed by
densitometry.
Interleukin-8 enzyme-linked immunosorbant assay
(ELISA)
Supernatants of control and infected Caco-2 cells were collected
and centrifuged for 10 min at 12 000 r.p.m. to pellet residual
bacteria and cells. IL-8 concentration was assessed using a
commercially available sandwich ELISA kit according to manu-
facturer’s instructions (R&D Systems, Abingdon, UK).
Demonstration of C. jejuni invasion by confocal
microscopy
Bacterial invasion of live versus PFA-fixed C. jejuni was inves-
tigated using confocal microscopy. Fluorescent labelling of WT
C. jejuni 81–176 was performed by incubating bacteria in PBS
containing 0.1 mg ml-1 FITC (Sigma-Aldrich, Gillingham, UK) for
15 min at room temperature. Bacteria were washed twice in
PBS to remove unbound FITC and resuspended in antibiotic-
free DMEM medium supplemented with 1% FCS. PFA inactiva-
tion of FITC-labelled bacteria was performed as described
above. Confluent Caco-2 cells grown on coverslips were
co-cultured with live or PFA-inactivated FITC-labelled C. jejuni
(MOI of 100) in DMEM for 5 h. Following washes with PBS,
cells were fixed in 4% PFA for 20 min. Non-specific binding was
blocked by incubating cells with 1% BSA for 45 min. Extracel-
lular bacteria were labelled with unconjugated goat anti-C. jejuni
antibodies (Kirkegaard and Perry Laboratories, Maryland, USA)
at a concentration of 5 mg ml-1 for 60 min at room temperature
followed by incubation with Alexa Fluor 568-conjugated rabbit
anti-goat IgG (Molecular Probes, Eugene, Oregon, USA) for
30 min. Bacteria and cell nuclei were counterstained with
TO-PRO-3 (Molecular Probes) for 30 min. Co-cultures were
visualized with a Radiance 2100 confocal laser scanning micro-
scope equipped with an Argon-Krypton laser and a red diode
(Bio-Rad, UK).
Transient transfection of IL-8 and hBD2 promoter
constructs
For promoter transcriptional analyses, Caco-2 cells were
seeded in a 96-well plate at a density of 2 ¥ 104 cells well-1 in
200 ml of DMEM and transient transfections performed at
60–80% cell confluence. Prior to transfection, FuGene reagent
(Roche, Lewes, UK) and Opti-MEM (Invitrogen) were mixed
and incubated at room temperature for a minimum of 15 min.
DNA was added in a ratio of 4:1 (FuGene in ml: DNA in mg) as
recommended by the manufacturer. Amount of DNA transfected
was equalized among experiments by the addition of varying
amounts of empty vector (pcDNA). Test promoter-luciferase
constructs IL-8 (kind gift from Dr A.G. Bowie, Dublin) or hBD2
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(Boughan et al., 2006) were cotransfected (60 ng well-1) with
Renilla luciferase construct (20 ng well-1), the latter used to
account for cell loss and transfection efficiency. The mixture
was added directly to cultured 96-well plates and incubated at
37°C for 24 h. For bacterial co-culture experiments, media was
replaced by 100 ml of DMEM containing C. jejuni cells (moi
100). 20 h post infection, cells were washed with 200 ml of PBS
prior to addition of passive lysis buffer (Promega, Southampton,
UK). Firefly and Renilla luciferase activity was measured using
a 96-well plate luminometer (Lucy 1; Anthos Biotech, Salzburg,
Austria).
Small interfering (si) RNA experiments siRNA sequences tar-
geting NOD1 (Sequence 1: sense GGC CAA AGU CUA UGA
AGA Utt, Sequence 2: sense GGG UGA GAC CAU CUU CAU
Ctt) and a non-targeting negative (siNEG) control sequence
(catalogue number AM 4611) were all purchased from Ambion
(Huntingdon, Cambridge UK). Caco-2 cells were reverse-
transfected with siRNA using siPORT NeoFX Transfection
Reagent (Ambion). siRNA was prepared in Opti-MEM serum-free
medium (Invitrogen) by mixing 0.7 or 0.8 ml of the transfection
reagent with 10 or 20 nM siRNA, respectively, at room tempera-
ture for 10 min. Caco-2 cells (8 ¥ 103 cells well-1) were trans-
ferred to a 96-well plate containing siRNA transfection reagent
complexes, allowing transfection to occur during initial cell
adherence. Media was replaced after 20 h by media containing
10% FCS (allowing cell recovery) and incubation continued for an
additional 28 h prior to bacterial infection. Gene knock-down was
confirmed by RT-PCR.
Transfection of Caco-2 cells with NOD2 overexpression
plasmid
100 ng NOD2 expressing plasmid was transfected into Caco-2
(8 ¥ 103) cells using FuGene reagent (Roche, Lewes, UK) as
described above. For luciferase reporter gene assays, NOD2
plasmid was cotransfected with IL-8 or hBD2 promoter
constructs. NOD2 expression was confirmed using RT-PCR and
bacterial co-culture studies performed 48 h post transfection.
C. jejuni invasion assay
Caco-2 cells were plated in a 96-well plate and reverse-
transfected with NOD1 siRNA or overexpressing NOD2 plasmid
as described above. After 48 h approximately 107 cfu of C. jejuni
81–176 cells were added to each well. Following a 20 h infection
period, cells were incubated in media containing gentamicin
(150 mg ml-1) for 60 min. This procedure ensured complete kill of
any adherent extracellular bacteria. Cells were washed three
times with PBS prior to lysis with 0.2% v/v Triton X-100 (in PBS)
for 15 min at room temperature. Serial dilutions were plated onto
blood agar plates.
Statistics
Results are presented as mean  SE. All experiments were con-
ducted at least three times with transfection and colonization
assays performed in triplicate in each experiment. Statistical
analyses were performed using GraphPad Instat statistical soft-
ware, variables were compared using a t-test, and a probability
value of < 0.05 was regarded as significant.
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